|
Market Cap (18-May) $41,071,320 (780th) |
Close (30-Jun) $0.081 |
Volume (30-Jun) 2,818,974 |
Shortsold (13-Feb) 21,991 (0.00%) (605th) |
|
52w High $0.063 |
52w Low $0.037 |
P/E - |
EPS -0.01 |
PTX released this announcement to the ASX on 23 August 2022, 10:49. The announcement is not marked as price sensitive, and is 59 page(s) in length and 2.62MB in size.
You can view all announcements from PTX and see how they appear on a price chart on the announcements page.
At the date of this announcement, PTX was 0.042% short sold according to ASIC data. It was ranked the 538th most shorted stock on the ASX. It remains ranked 605th as of the latest reported data (13 February 2024).
| Other Recent Announcements from PTX | |
|---|---|
| Application for quotation of securities - PTX | 14 June 2023, 15:38 |
| Two PTX abstracts accepted at prestigious ISCT conference | 16 May 2023, 8:59 |
| Initial Director's Interest Notice | 15 May 2023, 14:31 |
| PTX Presentation | 23 August 2022, 10:49 |
| Appendix 4G and Corporate Governance Statement | 23 August 2022, 9:53 |
| Appendix 4E and 2022 Annual Report | 23 August 2022, 9:51 |
| PTX agreement with Thermo Fisher for scalable OmniCAR | 18 August 2022, 9:08 |
You must be logged in to post a reply.
Prescient Therapeutics 